 |
Articles: Drug Approvals |
Prior Articles
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09
Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09
Free full text
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 09/25/09
Free full text
European Commission Grants Conditional Marketing Authorization to Cayston for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
Gilead, 09/24/09
Free full text
Analysis of Drug Authentication at the Point of Dispensing in Belgian and Greek Community Pharmacies
Annals of Pharmacotherapy, 09/23/09 Physio-Control Receives Market Approval from Health Canada for LIFEPAK 15 Monitor/Defibrillator
Medtronic, 09/23/09
Free full text
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Abbott, 09/22/09 Antineoplastic Agent / Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Tarceva®Application for Approval of Additional Indication of Pancreatic Cancer
Chugai Pharmaceutical Co., 09/21/09
Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 09/21/09
Free full text
Pivotal studies of orphan drugs approved for neurological diseases
Annals of Neurology, 09/18/09 APP Pharmaceuticals Receives Approval for Deferoxamine Mesylate for Injection, USP
American Pharmaceutical Partners, 09/18/09
Free full text
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Free full text
Bevacizumab: Monoclonal antibody approved for the treatment of metastatic renal cell carcinoma in combination with interferon alfa
Formulary, 09/17/09
Free full text
Saxagliptin: DPP-4 inhibitor approved for the treatment of type 2 diabetes mellitus
Formulary, 09/17/09
Free full text
Sanofi-aventis Receives Complete Response Letter from the FDA for Eplivanserin Submission
Sanofi-aventis, 09/17/09
Free full text
Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
Mylan, 09/17/09 FDA actions in brief, September 2009 (Saphris, Tracleer, Livalo, Tyvaso, Tekturna HCT, Onsolis, Forteo, Invega Sustenna, Colcrys, Acuvail, Lipsovir, Kogenate FS)
Formulary, 09/17/09
Free full text
ImmunoGen Announces Amgen has Licensed Rights to Use the Companys TAP Technology for a Solid Tumor Target
ImmunoGen, Inc., 09/17/09
Free full text
Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use
Drug Development Research, 09/16/09 U.S. FDA Licenses Sanofi Pasteurs Pandemic Influenza Vaccine
Sanofi-aventis, 09/16/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
